Breaking News Instant updates and real-time market news.

2020-12-03 11:56:53 HLF Herbalife Nutrition $49.80 / +1.09 (+2.24%) 11:56 12/03/20 12/03 11:56 12/03/20 11:56	Herbalife Nutrition participates in a conference call with Jefferies Financial Analyst Barbero holds a conference call with management on December 3 at 2 pm hosted by Jefferies.	03 Dec
HLF Herbalife Nutrition $49.80 / +1.09 (+2.24%) 09/11/20 Jefferies Herbalife, Nu Skin valuation gaps can close as models transform, says Jefferies 06/22/20 Citi Citi boosts Herbalife target to $63, opens '90 Day Catalyst Watch' 05/08/20 Jefferies Herbalife Nutrition price target raised to $45 from $40 at Jefferies 05/08/20 Citi Herbalife Nutrition price target raised to $56 from $49 at Citi

2020-12-03 11:56:53

HLF

Herbalife Nutrition

$49.80 / +1.09 (+2.24%)

11:56

12/03/20

12/03

11:56

12/03/20

11:56

Herbalife Nutrition participates in a conference call with Jefferies

Financial Analyst Barbero holds a conference call with management on December 3 at 2 pm hosted by Jefferies.

03
Dec

HLF Herbalife Nutrition

$49.80 / +1.09 (+2.24%)

09/11/20 Jefferies: Herbalife, Nu Skin valuation gaps can close as models transform, says Jefferies

06/22/20 Citi: Citi boosts Herbalife target to $63, opens '90 Day Catalyst Watch'

05/08/20 Jefferies: Herbalife Nutrition price target raised to $45 from $40 at Jefferies

05/08/20 Citi: Herbalife Nutrition price target raised to $56 from $49 at Citi

TODAY'S FREE FLY STORIES

Recommendations	Pinnacle Financial price target raised to $80 from $50 at Raymond James » 07:28 01/21/21 01/21 07:28 01/21/21 07:28 PNFP Pinnacle Financial $72.53 / +2.21 (+3.14%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events PNFP Pinnacle Financial $72.53 / +2.21 (+3.14%) 10/20/20 Pinnacle Financial declares16c per share quarterly cash dividend PNFP Pinnacle Financial $72.53 / +2.21 (+3.14%) 05:27 Today Keefe Bruyette Pinnacle Financial price target raised to $80 from $60 at Keefe Bruyette 01/04/21 Wells Fargo Pinnacle Financial downgraded to Equal Weight from Overweight at Wells Fargo 12/15/20 JPMorgan Pinnacle Financial upgraded to Overweight from Neutral at JPMorgan 11/16/20 Stephens Pinnacle Financial resumed with an Overweight at Stephens PNFP Pinnacle Financial $72.53 / +2.21 (+3.14%) 01/19/21 Pinnacle Financial reports Q4 EPS $1.58 ex-items, consensus $1.35 01/19/21 Pinnacle Financial reports Q4 EPS $1.58 ex-items, consensus $1.35 01/19/21 Notable companies reporting after market close 10/20/20 Pinnacle Financial reports Q3 EPS $1.42, consensus $1.09 03/11/21 Virtual Atlanta and Texas Bank Summit
Upgrade	Signature Aviation upgraded to Hold from Sell at Berenberg » 07:27 01/21/21 01/21 07:27 01/21/21 07:27 BBAVF Signature Aviation $0.00 / + (+0.00%) Berenberg analyst Eoghan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News BBAVF Signature Aviation $0.00 / + (+0.00%) 12/21/20 Signature Aviation to recommend $5.17 per share offer from Blackstone
Hot Stocks	Skylight Health announces re-opening of four primary care clinics » 07:27 01/21/21 01/21 07:27 01/21/21 07:27 SHGFF Skylight Health $0.00 / + (+0.00%) Skylight Health Group is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News SHGFF Skylight Health $0.00 / + (+0.00%) 01/14/21 Skylight Health appoints Grace Mellis to board of directors 01/12/21 Skylight Health announces 75% voluntary share lock-up 01/07/21 Skylight Health to acquire U.S. clinic group for C$14.3M 01/06/21 Skylight Health announces voluntary lock-up agreements with founders, executives
Downgrade	BJ's Restaurants downgraded to Hold after 42% rally at Deutsche Bank » 07:26 01/21/21 01/21 07:26 01/21/21 07:26 BJRI BJ's Restaurants $47.36 / -1.2 (-2.47%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly BJRI BJ's Restaurants $47.36 / -1.2 (-2.47%) 09/01/20 Four Corners announces acquisition of a BJ's Restaurant property for $3.1M 07/23/20 BJ's Restaurants reports Q2 comparable sales decline of 57.2% BJRI BJ's Restaurants $47.36 / -1.2 (-2.47%) 01/20/21 Deutsche Bank BJ's Restaurants downgraded to Hold from Buy at Deutsche Bank 01/07/21 Stephens BJ's Restaurants upgraded to Overweight on casual dining 'boom' at Stephens 01/07/21 Stephens BJ's Restaurants upgraded to Overweight from Equal Weight at Stephens 12/17/20 Wells Fargo BJ's Restaurants upgraded to Overweight from Equal Weight at Wells Fargo BJRI BJ's Restaurants $47.36 / -1.2 (-2.47%) 10/22/20 BJ's Restaurants reports Q3 EPS (30c), consensus (71c) 07/23/20 BJ's Restaurants reports Q2 EPS ($1.38), consensus ($1.95) BJRI BJ's Restaurants $47.36 / -1.2 (-2.47%) 12/17/20 AT&T downgrade, Yum! Brands upgrade among today's top calls on Wall Street 07/23/20 Fly Intel: After-Hours Movers
Recommendations	Haemonetics price target raised to $140 from $110 at JMP Securities » 07:23 01/21/21 01/21 07:23 01/21/21 07:23 HAE Haemonetics / + JMP Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events HAE Haemonetics / + 01/20/21 Haemonetics acquires Cardiva Medical for over $475M 10/21/20 Haemonetics rises 11.8% 10/04/20 Haemonetics receives FDA clearance for NexSys PCS with Persona technology 08/04/20 Haemonetics falls -11.1% HAE Haemonetics / + 11/05/20 Barrington Haemonetics upgraded to Outperform from Market Perform at Barrington 07/01/20 Raymond James Haemonetics price target lowered to $113 from $125 at Raymond James 05/06/20 Barrington Haemonetics downgraded to Market Perform from Outperform at Barrington 04/07/20 Raymond James Haemonetics price target lowered to $130 from $150 at Raymond James HAE Haemonetics / + 11/04/20 Haemonetics reports Q2 adj. EPS 62c, consensus 51c 08/04/20 Haemonetics reports Q1 adj. EPS 46c, consensus 41c 02/02/21 Haemonetics - HAE

Recommendations	Hancock Whitney price target raised to $46 from $28 at Raymond James » 07:23 01/21/21 01/21 07:23 01/21/21 07:23 HWC Hancock Whitney $39.51 / -0.69 (-1.72%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings On The Fly Events HWC Hancock Whitney $39.51 / -0.69 (-1.72%) 01/07/21 Jefferies Hancock Whitney upgraded to Buy with $42 price target at Jefferies 01/07/21 Jefferies Hancock Whitney upgraded to Buy from Hold at Jefferies 10/08/20 BofA Texas Capital downgraded to Underperform at BofA as part of pair trade 10/08/20 BofA Hancock Whitney upgraded to Buy at BofA as part of Texas Capital pair trade HWC Hancock Whitney $39.51 / -0.69 (-1.72%) 01/20/21 Hancock Whitney reports Q4 EPS $1.17, consensus 90c 10/20/20 Hancock Whitney reports Q3 EPS 90c, consensus 70c 07/21/20 Hancock Whitney reports Q2 ex-items EPS 11c, consensus 36c HWC Hancock Whitney $39.51 / -0.69 (-1.72%) 01/20/21 Fly Intel: After-Hours Movers 10/20/20 Fly Intel: After-Hours Movers 03/11/21 Virtual Atlanta and Texas Bank Summit
Downgrade	Benefitfocus downgraded at Raymond James on 'aggressive' consensus estimates » 07:22 01/21/21 01/21 07:22 01/21/21 07:22 BNFT Benefitfocus $14.43 / -0.19 (-1.30%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings BNFT Benefitfocus $14.43 / -0.19 (-1.30%) 11/02/20 Benefitfocus appoints John Thomas as Chief Data Officer 09/08/20 Benefitfocus appoints Robin Kirby as Chief Human Resources Officer 08/24/20 Benefitfocus CEO Raymond August steps down, Stephen Swad succeeds BNFT Benefitfocus $14.43 / -0.19 (-1.30%) 04:48 Today Raymond James Benefitfocus downgraded to Market Perform from Outperform at Raymond James 11/06/20 Cantor Fitzgerald Benefitfocus downgraded to Neutral from Overweight at Cantor Fitzgerald 11/06/20 Cantor Fitzgerald Benefitfocus downgraded to Neutral from Overweight at Cantor Fitzgerald 08/06/20 Piper Sandler Benefitfocus price target raised to $30 from $26 at Piper Sandler BNFT Benefitfocus $14.43 / -0.19 (-1.30%) 08/24/20 Benefitfocus backs FY20 EPS view (59c)-(44c), consensus (49c) 08/24/20 Benefitfocus backs Q3 EPS view (21c)-(12c), consensus (14c) 08/05/20 Benefitfocus sees FY20 EPS (59c)-(44c), consensus (50c) 08/05/20 Benefitfocus sees Q3 EPS (21c)-(12c), consensus (17c)
Downgrade	KeyBanc cuts VMware to Sector Weight ahead of 'more challenging first half' » 07:21 01/21/21 01/21 07:21 01/21/21 07:21 VMW VMware $132.61 / +0.405 (+0.31%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options VMW VMware $132.61 / +0.405 (+0.31%) 01/13/21 VMware names CFO Rowe interim CEO, board starts search 01/13/21 Intel appoints VMware's Pat Gelsinger as new CEO, Swan to step down 01/13/21 Intel jumps 13% after CNBC says CEO Swan to be replaced 01/05/21 Pure Storage appoints Ajay Singh as Chief Product Officer VMW VMware $132.61 / +0.405 (+0.31%) 06:00 Today KeyBanc VMware downgraded to Sector Weight from Overweight at KeyBanc 01/15/21 Evercore ISI Evercore adds Dell Technologies to tactical Outperform list, ups target to $85 01/14/21 UBS VMware price target lowered to $145 from $152 at UBS 01/14/21 BMO Capital AMD downgraded to Underperform from Market Perform at BMO Capital VMW VMware $132.61 / +0.405 (+0.31%) 11/24/20 VMware sees FY22 revenue up high single digits, consensus $12.82B 11/24/20 VMware sees FY21 EPS $7.03, consensus $6.66 11/24/20 VMware sees Q4 EPS $2.04, consensus $1.88 11/24/20 VMware raises FY21 EPS view to $7.03 from $6.62, consensus $6.66 VMW VMware $132.61 / +0.405 (+0.31%) 01/13/21 Intel CEO Swan stepping down, WMware CEO Gelsinger to replace him, CNBC says 01/13/21 Intel CEO Swan to be replaced by VMware's Pat Gelsinger, CNBC reports 01/13/21 Intel CEO Bob Swan to step down, to be replaced by Gelsinger, CNBC reports 12/21/20 Tech giants join Facebook's legal battle against Israel's NSO, Reuters says VMW VMware $132.61 / +0.405 (+0.31%) 01/14/21 AMD slips as analyst says sell on Gelsinger's return to Intel 01/14/21 Shopify, Intel upgrades among today's top calls on Wall Street 01/13/21 Fly Intel: Wall Street's top stories for Wednesday 01/13/21 VMware slides as Gelsinger returns to Intel to be new CEO VMW VMware $132.61 / +0.405 (+0.31%) 12/18/20 VMware put volume heavy and directionally bearish 10/27/20 Largest borrow rate increases among liquid names 10/26/20 VMware put volume heavy and directionally bearish
Upgrade	EastGroup Properties upgraded to Buy from Neutral at BTIG » 07:20 01/21/21 01/21 07:20 01/21/21 07:20 EGP EastGroup Properties $138.58 / +4.91 (+3.67%) BTIG analyst Thomas… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events EGP EastGroup Properties $138.58 / +4.91 (+3.67%) 09/03/20 EastGroup Properties says operating portolio was 97.3% leased in August 08/27/20 EastGroup Properties raises quarterly dividend to 79c from 75c per share EGP EastGroup Properties $138.58 / +4.91 (+3.67%) 01/13/21 Jefferies First Industrial Realty upgraded to Buy with $49 price target at Jefferies 11/16/20 Mizuho EastGroup Properties price target raised to $145 from $138 at Mizuho 09/22/20 Baird EastGroup Properties initiated with a Neutral at Baird 08/24/20 Truist Truist raises price targets on select REITs EGP EastGroup Properties $138.58 / +4.91 (+3.67%) 10/27/20 EastGroup Properties raises FY20 FFO view to $5.33-$5.37 from $5.23-$5.33 10/27/20 EastGroup Properties reports Q3 FFO $1.36, consensus 69c 07/28/20 EastGroup Properties raises FY20 FFO view to $5.23-$5.33 from $5.11-$5.23 07/28/20 EastGroup Properties reports Q2 FFO $1.33, consensus $1.27 02/24/21 24th Annual Real Estate Securities Virtual Conference 02/10/21 EastGroup Properties - EGP
Upgrade	Dillard's upgraded to Hold from Sell at Deutsche Bank » 07:19 01/21/21 01/21 07:19 01/21/21 07:19 DDS Dillard's $69.37 / +0.28 (+0.41%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options DDS Dillard's $69.37 / +0.28 (+0.41%) 10/12/20 Dillard's rises 32.0% 10/12/20 Dillard's rises 24.0% 10/12/20 Dillard's rises 19.5% 10/09/20 R. Ted Weschler reports 5.89% passive stake in Dillard's DDS Dillard's $69.37 / +0.28 (+0.41%) 06:07 Today Deutsche Bank Dillard's upgraded to Hold from Sell at Deutsche Bank 01/04/21 JPMorgan Dillard's price target raised to $42 from $41 at JPMorgan 12/23/20 Wedbush Dillard's price target raised to $60 from $46 at Wedbush 11/13/20 Deutsche Bank Dillard's price target raised to $31 from $27 at Deutsche Bank DDS Dillard's $69.37 / +0.28 (+0.41%) 11/12/20 Dillard's reports Q3 EPS $1.43c vs 22c last year 08/13/20 Dillard's reports Q2 EPS (37c), consensus ($4.54) DDS Dillard's $69.37 / +0.28 (+0.41%) 11/12/20 Fly Intel: After-Hours Movers 10/12/20 Fly Intel: Wall Street's top stories for Monday 10/12/20 Fly Intel: Wall Street's top stories at midday 08/13/20 Fly Intel: After-Hours Movers DDS Dillard's $69.37 / +0.28 (+0.41%) 11/09/20 Largest borrow rate increases among liquid names 10/16/20 Largest borrow rate increases among liquid names 09/16/20 Largest borrow rate increases among liquid names 09/11/20 Largest borrow rate increases among liquid names

Upgrade	Fastly upgraded to Outperform at Oppenheimer » 07:18 01/21/21 01/21 07:18 01/21/21 07:18 FSLY Fastly $97.64 / +2.305 (+2.42%) , NET Cloudflare $83.52 / +2.195 (+2.70%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options FSLY NET FSLY Fastly $97.64 / +2.305 (+2.42%) 11/13/20 Fastly rises after Commerce says won't enforce TikTok shutdown order 10/30/20 Fastly issues update to Q3 shareholder letter 10/23/20 Fastly falls -6.5% 10/15/20 Fastly falls -23.7% NET Cloudflare $83.52 / +2.195 (+2.70%) 10/12/20 Cloudflare spikes higher after announcing Cloudflare One FSLY NET FSLY Fastly $97.64 / +2.305 (+2.42%) 06:13 Today Oppenheimer Fastly upgraded to Outperform from Perform at Oppenheimer 11/25/20 Credit Suisse Fastly downgraded to Neutral after recent rally at Credit Suisse 11/25/20 Credit Suisse Fastly downgraded to Neutral from Outperform at Credit Suisse 10/30/20 Piper Sandler Piper Sandler remains Underweight on Fastly following management update NET Cloudflare $83.52 / +2.195 (+2.70%) 01/19/21 RBC Capital Cloudflare price target raised to $85 from $70 at RBC Capital 12/15/20 BTIG BTIG raises price targets on select security and software applications names 12/09/20 JPMorgan Cloudflare downgraded to Neutral from Overweight at JPMorgan 12/01/20 Fly Intel: Top five analyst initiations FSLY NET FSLY Fastly $97.64 / +2.305 (+2.42%) 10/28/20 Fastly reports Q3 EPS (4c), consensus 0c 10/28/20 Notable companies reporting after market close 10/14/20 Fastly cuts Q3 revenue view to $70M-$71M from $73.5M-$75.5M, consensus $74.77M 08/05/20 Fastly raises FY20 adj. EPS view to (6c)-(1c) from (15c)-(8c), consensus (13c) NET Cloudflare $83.52 / +2.195 (+2.70%) 11/05/20 Cloudflare raises FY20 adj. EPS view to (13c)-(12c) from (18c)-(17c) 11/05/20 Cloudflare sees Q4 adjusted EPS (4c)-(3c), consensus (5c) 11/05/20 Cloudflare reports Q3 adjusted EPS (2c), consensus (5c) 11/05/20 Notable companies reporting after market close 21 May FSLY NET FSLY Fastly $97.64 / +2.305 (+2.42%) 12/08/20 Cloudflare, Fastly working with Apple to create Oblivious DNS, AppleInsider says NET Cloudflare $83.52 / +2.195 (+2.70%) 12/08/20 Cloudflare, Fastly working with Apple to create Oblivious DNS, AppleInsider says 09/01/20 Hackers test security of Trump campaign sites ahead of election, Reuters says FSLY NET FSLY Fastly $97.64 / +2.305 (+2.42%) 12/08/20 Fastly jumps after report of DNS work with Apple 11/13/20 Fly Intel: Pre-market Movers 10/23/20 Intel, Fastly downgrades among today's top calls on Wall Street 10/15/20 Fly Intel: Wall Street's top stories for Thursday NET Cloudflare $83.52 / +2.195 (+2.70%) 12/09/20 JPMorgan downgrades Zoom, upgrades Autodesk in software ratings shakeup 12/08/20 Fastly jumps after report of DNS work with Apple 11/06/20 Fly Intel: Pre-market Movers 11/05/20 Fly Intel: After-Hours Movers 02/11/21 Cloudflare - NET 02/17/21 Fastly - FSLY 02/12/21 Cloudflare, Inc. FSLY NET FSLY Fastly $97.64 / +2.305 (+2.42%) 01/19/21 Fastly Inc call volume above normal and directionally bullish 12/18/20 Fastly Inc call volume above normal and directionally bullish 12/11/20 Unusually active option classes on open December 11th 12/10/20 Fastly Inc call volume above normal and directionally bullish NET Cloudflare $83.52 / +2.195 (+2.70%) 01/08/21 Cloudflare call volume above normal and directionally bullish 12/24/20 Cloudflare call volume above normal and directionally bullish 12/18/20 Cloudflare call volume above normal and directionally bullish 12/14/20 Cloudflare call volume above normal and directionally bullish
Hot Stocks	Fifth Third sees 1Q21 NIM down 4-5bps vs. 4Q20 » 07:17 01/21/21 01/21 07:17 01/21/21 07:17 FITB Fifth Third $31.32 / -0.75 (-2.34%) Sees Q1 average loans and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events FITB Fifth Third $31.32 / -0.75 (-2.34%) 07:16 Today Fifth sees FY21 underlying NIM in the 3% range ex-excess cash, PPP impacts 07:11 Today Fifth Third expects to repurchase up to $180M in Q1 06:39 Today Fifth Third CEO says capital, liquidity levels 'further improved' in Q4 06:32 Today Fifth Third reports Q4 net interest margin 2.58% vs. 3.27% a year ago FITB Fifth Third $31.32 / -0.75 (-2.34%) 01/07/21 Goldman Sachs Fifth Third upgraded to Buy from Neutral at Goldman Sachs 01/06/21 Deutsche Bank Fifth Third price target raised to $30 from $24 at Deutsche Bank 01/04/21 Barclays Fifth Third price target raised to $37 from $28 at Barclays 12/07/20 Evercore ISI Fifth Third upgraded to In Line from Underperform at Evercore ISI FITB Fifth Third $31.32 / -0.75 (-2.34%) 06:31 Today Fifth Third reports Q4 EPS 78c, consensus 69c 10/22/20 Fifth Third reports Q3 EPS 78c, consensus 60c 10/21/20 Notable companies reporting before tomorrow's open 10/21/20 Notable companies reporting before tomorrow's open FITB Fifth Third $31.32 / -0.75 (-2.34%) 01/20/21 Notable companies reporting before tomorrow's open 01/20/21 Notable companies reporting before tomorrow's open 11/21/20 Citizens Financial, Truist among regional bank stocks to grab, Barron's says 08/15/20 PNC, KeyCorp among large regional banks offering steady dividends, Barron's says FITB Fifth Third $31.32 / -0.75 (-2.34%) 09/25/20 Cruise Line upgrades among today's top calls on Wall Street 09:00 Today Fifth Third - FITB
Hot Stocks	Intrusion appoints Joe Head as SVP, sales engineering » 07:17 01/21/21 01/21 07:17 01/21/21 07:17 INTZ Intrusion $24.43 / -0.575 (-2.30%) INTRUSION is expanding… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate INTZ Intrusion $24.43 / -0.575 (-2.30%) 01/13/21 Intrusion completes beta testing of Shield cybersecurity solution 12/24/20 Intrusion director Michael Paxton resigns from board 12/14/20 Intrusion appoints Vittal Krishnamurthy as VP of product 12/01/20 Intrusion appoints Franklin Byrd as CFO INTZ Intrusion $24.43 / -0.575 (-2.30%) 01/14/21 B. Riley Securities Intrusion price target raised to $30 from $17 at B. Riley Securities 12/10/20 B. Riley Securities Intrusion price target raised to $17 from $15 at B. Riley Securities 10/15/20 B. Riley Securities B. Riley sees 'transformational growth' for Intrusion, starts with Buy rating 10/14/20 B. Riley Securities Intrusion initiated with a Buy at B. Riley Securities 09 Oct
Hot Stocks	BiondVax names Amir Reichman as new CEO » 07:16 01/21/21 01/21 07:16 01/21/21 07:16 BVXV BiondVax $4.23 / -0.09 (-2.08%) , GSK GlaxoSmithKline $38.02 / -0.51 (-1.32%) BiondVax (BVXV) announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BVXV GSK BVXV BiondVax $4.23 / -0.09 (-2.08%) 10/23/20 BiondVax down 88% to $4.64 after reporting trial failed to hit efficacy targets 10/23/20 BiondVax trading resumes 10/23/20 BiondVax to resume trading at 11:10 am ET 10/23/20 BiondVax says Phase 3 trial of M-001 failed to meet efficacy endpoints GSK GlaxoSmithKline $38.02 / -0.51 (-1.32%) 01/12/21 Vir Biotechnology, GlaxoSmithKline to evaluate VIR-7832 in COVID-19 patients 01/11/21 Eligo Bioscience enters research, option agreement with GlaxoSmithKline 12/21/20 Ligand, GSK in pact 'leveraging' Icagen's small molecule 'expertise' 12/17/20 Hikma Pharmaceuticals launches generic Advair Diskus following FDA approval BVXV GSK BVXV BiondVax $4.23 / -0.09 (-2.08%) GSK GlaxoSmithKline $38.02 / -0.51 (-1.32%) 01/20/21 UBS GlaxoSmithKline price target raised to 1,450 GBp from 1,440 GBp at UBS 01/20/21 Fly Intel: Top five analyst downgrades 01/20/21 Credit Suisse GlaxoSmithKline downgraded to Underperform from Neutral at Credit Suisse 01/20/21 Credit Suisse GlaxoSmithKline downgraded to Underperform from Neutral at Credit Suisse GSK GSK GlaxoSmithKline $38.02 / -0.51 (-1.32%) 10/28/20 GlaxoSmithKline now sees 2020 adjusted EPS at lower end of down 1%-4% range 10/28/20 GlaxoSmithKline reports Q3 adjusted EPS 35.6p vs. 38.6p a year ago 10/08/20 GlaxoSmithKline sees impact of foreign exchange on Q3 sales of about 5% 07/29/20 GlaxoSmithKline reports Q2 adjusted EPS 19.2p, down 37% AER GSK GSK GlaxoSmithKline $38.02 / -0.51 (-1.32%) 01/12/21 GSK looks to double blockbusters in portfolio by 2026, Bloomberg says 12/31/20 Drugmakers to hike U.S. prices on over 200 drugs, Reuters reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 12/11/20 GlaxoSmithKline offered $120 per share for Eidos Therapeutics, Bloomberg says GSK GSK GlaxoSmithKline $38.02 / -0.51 (-1.32%) 12/31/20 Fly Intel: Wall Street's top stories for Thursday 12/26/20 Week in review: How Trump's policies moved stocks 12/11/20 Fly Intel: Wall Street's top stories for Friday 12/11/20 Fly Intel: Wall Street's top stories at midday 03/02/21 2021 London Global Healthcare Virtual Conference 02/03/21 GlaxoSmithKline - GSK GSK GSK GlaxoSmithKline $38.02 / -0.51 (-1.32%) 09/04/20 GlaxoSmithKline call volume above normal and directionally bullish 08/03/20 Unusually active option classes on open August 3rd 07/31/20 Unusually active option classes on open July 31st
Hot Stocks	Fifth sees FY21 underlying NIM in the 3% range ex-excess cash, PPP impacts » 07:16 01/21/21 01/21 07:16 01/21/21 07:16 FITB Fifth Third $31.32 / -0.75 (-2.34%) Sees FY21 NII down about… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events FITB Fifth Third $31.32 / -0.75 (-2.34%) 07:11 Today Fifth Third expects to repurchase up to $180M in Q1 06:39 Today Fifth Third CEO says capital, liquidity levels 'further improved' in Q4 06:32 Today Fifth Third reports Q4 net interest margin 2.58% vs. 3.27% a year ago 01/04/21 Fifth Third completes acquisition of Hammond Hanlon Camp FITB Fifth Third $31.32 / -0.75 (-2.34%) 01/07/21 Goldman Sachs Fifth Third upgraded to Buy from Neutral at Goldman Sachs 01/06/21 Deutsche Bank Fifth Third price target raised to $30 from $24 at Deutsche Bank 01/04/21 Barclays Fifth Third price target raised to $37 from $28 at Barclays 12/07/20 Evercore ISI Fifth Third upgraded to In Line from Underperform at Evercore ISI FITB Fifth Third $31.32 / -0.75 (-2.34%) 06:31 Today Fifth Third reports Q4 EPS 78c, consensus 69c 10/22/20 Fifth Third reports Q3 EPS 78c, consensus 60c 10/21/20 Notable companies reporting before tomorrow's open 10/21/20 Notable companies reporting before tomorrow's open FITB Fifth Third $31.32 / -0.75 (-2.34%) 01/20/21 Notable companies reporting before tomorrow's open 01/20/21 Notable companies reporting before tomorrow's open 11/21/20 Citizens Financial, Truist among regional bank stocks to grab, Barron's says 08/15/20 PNC, KeyCorp among large regional banks offering steady dividends, Barron's says FITB Fifth Third $31.32 / -0.75 (-2.34%) 09/25/20 Cruise Line upgrades among today's top calls on Wall Street 09:00 Today Fifth Third - FITB

Hot Stocks	Calibre Mining announces start of open-pit mining at Pavon Norte » 07:16 01/21/21 01/21 07:16 01/21/21 07:16 CXBMF Calibre Mining $0.00 / + (+0.00%) Calibre Mining announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research CXBMF Calibre Mining $0.00 / + (+0.00%) 01/12/21 Calibre Mining sees 2021 production, sales of 170,000-180,000 ounces of gold 01/12/21 Calibre Mining reports 2020 production of 136,009 ounces of gold 01/12/21 Calibre Mining reports Q4 production of 42,573 ounces of gold 11/19/20 Calibre Mining provides update on generative exploration program CXBMF Calibre Mining $0.00 / + (+0.00%) 01/14/21 BMO Capital Calibre Mining initiated with a Market Perform at BMO Capital 10/13/20 Scotiabank Calibre Mining price target raised to C$3 from C$2.75 at Scotiabank 08/12/20 Raymond James Calibre Mining price target raised to C$2.50 from C$2.25 at Raymond James 05/14/20 Roth Capital Roth Capital bullish on Calibre Mining, initiates with a Buy
Periodicals	Starboard wants to take control of Corteva's board, replace CEO, WSJ reports » 07:15 01/21/21 01/21 07:15 01/21/21 07:15 CTVA Corteva $43.67 / +0.15 (+0.34%) Starboard Value LP, led… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events CTVA Corteva $43.67 / +0.15 (+0.34%) 01/19/21 Matrix Service subsidiary awarded construction of water facility by Corteva 01/04/21 Corteva welcomes new Chief Technology Officer Sam Eathington 12/23/20 Tyson Foods appoints Megan Britt as VP, investor relations 11/13/20 Starboard Value takes Corteva stake, exits eBay CTVA Corteva $43.67 / +0.15 (+0.34%) 05:12 Today Redburn Corteva downgraded to Neutral from Buy at Redburn 01/19/21 Deutsche Bank Corteva named 'Catalyst Call: Buy Idea' at Deutsche Bank 01/08/21 Deutsche Bank Corteva price target raised to $50 from $40 at Deutsche Bank 12/18/20 Susquehanna Corteva downgraded to Neutral from Positive at Susquehanna CTVA Corteva $43.67 / +0.15 (+0.34%) 11/04/20 Corteva backs FY20 operating EPS view $1.25-$1.45, consensus $1.38 11/04/20 Corteva reports Q3 adjusted EPS (39c), consensus (42c) 11/04/20 Notable companies reporting after market close 08/05/20 Corteva sees FY20 operating EPS $1.25-$1.45, consensus $1.40 CTVA Corteva $43.67 / +0.15 (+0.34%) 11/19/20 Corteva board backs CEO amid pressure from Starboard, Reuters says 10/09/20 Starboard makes new bets on Corteva, ON Semiconductor, Reuters reports 02/04/21 Corteva - CTVA
Upgrade	Tellurian upgraded to Outperform with $5 target at Wolfe Research » 07:14 01/21/21 01/21 07:14 01/21/21 07:14 TELL Tellurian $2.48 / -0.105 (-4.06%) Wolfe Research analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TELL Tellurian $2.48 / -0.105 (-4.06%) 07/21/20 Tellurian surges as Petronet reportedly renews investment agreement TELL Tellurian $2.48 / -0.105 (-4.06%) 01/20/21 Wolfe Research Tellurian upgraded to Outperform from Peer Perform at Wolfe Research 06/10/20 Fly Intel: Top five analyst initiations 06/10/20 Roth Capital Tellurian initiated with a Buy at Roth Capital 06/01/20 Stifel Tellurian downgraded to Sell from Hold at Stifel TELL Tellurian $2.48 / -0.105 (-4.06%) 08/05/20 Tellurian reports Q2 EPS (53c), consensus (11c) TELL Tellurian $2.48 / -0.105 (-4.06%) 07/21/20 Petronet renews deal over $2.5B investment in Tellurian project, Reuters says TELL Tellurian $2.48 / -0.105 (-4.06%) 07/21/20 Fly Intel: Wall Street's top stories for Tuesday 03/01/21 26th Annual Energy Virtual Summit TELL Tellurian $2.48 / -0.105 (-4.06%) 11/05/20 Tellurian options imply 41.6% move in share price post-earnings 11/05/20 Largest borrow rate increases among liquid names 11/03/20 Largest borrow rate increases among liquid names 10/27/20 Largest borrow rate increases among liquid names
Hot Stocks	Genetic Technologies provides update on COVID-19 disease severity risk test » 07:14 01/21/21 01/21 07:14 01/21/21 07:14 GENE Genetic Technologies $4.32 / -0.03 (-0.69%) Genetic Technologies… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Options GENE Genetic Technologies $4.32 / -0.03 (-0.69%) 12/02/20 Genetic Technologies secures U.S., Australia distribution rights for Predictix 10/01/20 Genetic Technologies outlines findings in relation to COVID-19 Risk Test 09/15/20 Genetic Technologies offers update on COVID-19 disease severity test development 09/11/20 Genetic Technologies commences U.S. sales via online health platform GENE Genetic Technologies $4.32 / -0.03 (-0.69%) 01/05/21 Largest borrow rate increases among liquid names 12/23/20 Largest borrow rate increases among liquid names 07/29/20 Thirteen new option listings on July 29th
Recommendations	Expedia price target raised to $164 from $145 at Truist » 07:12 01/21/21 01/21 07:12 01/21/21 07:12 EXPE Expedia $141.75 / -0.99 (-0.69%) Truist analyst Naved Khan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options EXPE Expedia $141.75 / -0.99 (-0.69%) 12/08/20 Porch.com appoints Matthew Cullen as general counsel, secretary 11/13/20 Third Point takes stake in PG&E, boosts Alibaba stake, exits Baxter 11/04/20 Expedia: July was down in lodgings and gross bookings 11/04/20 Expedia reports Q3 room night growth down 58% EXPE Expedia $141.75 / -0.99 (-0.69%) 01/15/21 BTIG Expedia price target raised to $175 from $145 at BTIG 01/15/21 JMP Securities Expedia price target raised to $165 from $115 at JMP Securities 01/08/21 Mizuho Expedia price target raised to $115 from $95 at Mizuho 01/04/21 Deutsche Bank Expedia price target raised to $148 from $108 at Deutsche Bank EXPE Expedia $141.75 / -0.99 (-0.69%) 11/04/20 Expedia reports Q3 adjusted EPS (22c), consensus (79c) 11/04/20 Notable companies reporting after market close 07/30/20 Expedia reports Q2 EPS ($4.09), consensus ($3.34) 07/30/20 Expedia reports Q2 adjusted EPS ($4.09), consensus ($3.34) EXPE Expedia $141.75 / -0.99 (-0.69%) 11/20/20 Tech giants threaten to exit Pakistan over censorship law, TechCrunch says 10/23/20 TripAdvisor CEO welcomes DOJ move to look into Google, CNBC reports 09/29/20 Amazon gets into virtual tourism, with Amazon Explore, GeekWire reports 07/30/20 Affirm preparing IPO for up to $10B, WSJ reports EXPE Expedia $141.75 / -0.99 (-0.69%) 01/04/21 Airbnb under pressure as Wall Street analysts roll out coverage following IPO 12/14/20 Disney, Airbnb downgrades among today's top calls on Wall Street 12/10/20 Tesla downgrade, Disney initiation among today's top calls on Wall Street 12/01/20 Pinterest, FedEx upgrades among today's top calls on Wall Street EXPE Expedia $141.75 / -0.99 (-0.69%) 12/16/20 Expedia call volume above normal and directionally bullish 12/10/20 Expedia call volume above normal and directionally bullish 11/20/20 Expedia call volume above normal and directionally bullish 11/05/20 Early notable gainers among liquid option names on November 5th

Recommendations	Apple price target raised to $152 from $144 at Morgan Stanley » 07:12 01/21/21 01/21 07:12 01/21/21 07:12 AAPL Apple $131.98 / +4.13 (+3.23%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AAPL Apple $131.98 / +4.13 (+3.23%) 01/19/21 Netflix says past year 'testament' to company's approach 01/17/21 Fly Intel: Top five weekend stock stories 01/15/21 VirnetX says court affirms jury award of $502.8M against Apple 01/15/21 VirnetX jumps after court denies Apple motion for new patent trial AAPL Apple $131.98 / +4.13 (+3.23%) 01/19/21 Craig-Hallum Lumentum acquisition of Coherent 'a good fit in many ways,' says Craig-Hallum 01/19/21 BMO Capital Facebook upgraded to Outperform from Market Perform at BMO Capital 01/15/21 Goldman Sachs Goldman Sachs raises short-term forecasts for Apple, maintains Sell rating 01/15/21 Loop Capital Apple price target raised to $155 from $131 at Loop Capital AAPL Apple $131.98 / +4.13 (+3.23%) 10/29/20 Apple says Q4 results were ahead of expectations 10/29/20 Apple reports Q4 Services revenue $14.55B vs. $12.51B last year 10/29/20 Apple reports Q4 iPhone revenue $24.44B vs. $33.36B last year 10/29/20 Apple reports Q4 EPS 73c, consensus 70c AAPL Apple $131.98 / +4.13 (+3.23%) 06:34 Today Apple's first headset to focus on virtual reality, Bloomberg reports 01/17/21 Apple considering foldable iPhone, minor changes for 2021 models, Bloomberg says 01/17/21 Google might face 4th government suit over business practices, Reuters says 01/15/21 Apple to re-close stores in Texas, North Carolina, Georgia, Bloomberg says AAPL Apple $131.98 / +4.13 (+3.23%) 01/20/21 #SocialStocks: Facebook could be in focus under new administration 01/20/21 Street Fight: Analysts diverge on Lumentum after Coherent deal announcement 01/19/21 Lumentum slides after announcing $5.7B merger deal with Coherent 01/19/21 Facebook upgrade, Roku initiation among today's top calls on Wall Street 01/27/21 Apple - AAPL 02/23/21 Apple, Inc. AAPL Apple $131.98 / +4.13 (+3.23%) 01/20/21 Notable open interest changes for January 20th 01/19/21 Notable open interest changes for January 19th 01/15/21 Notable open interest changes for January 15th 01/14/21 Notable open interest changes for January 14th
Hot Stocks	Fifth Third expects to repurchase up to $180M in Q1 » 07:11 01/21/21 01/21 07:11 01/21/21 07:11 FITB Fifth Third $31.32 / -0.75 (-2.34%) Comments taken from Q4… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events FITB Fifth Third $31.32 / -0.75 (-2.34%) 06:39 Today Fifth Third CEO says capital, liquidity levels 'further improved' in Q4 06:32 Today Fifth Third reports Q4 net interest margin 2.58% vs. 3.27% a year ago 01/04/21 Fifth Third completes acquisition of Hammond Hanlon Camp 12/07/20 Fifth Third Bank announces $2.8B investment to accelerate racial equity FITB Fifth Third $31.32 / -0.75 (-2.34%) 01/07/21 Goldman Sachs Fifth Third upgraded to Buy from Neutral at Goldman Sachs 01/06/21 Deutsche Bank Fifth Third price target raised to $30 from $24 at Deutsche Bank 01/04/21 Barclays Fifth Third price target raised to $37 from $28 at Barclays 12/07/20 Evercore ISI Fifth Third upgraded to In Line from Underperform at Evercore ISI FITB Fifth Third $31.32 / -0.75 (-2.34%) 06:31 Today Fifth Third reports Q4 EPS 78c, consensus 69c 10/22/20 Fifth Third reports Q3 EPS 78c, consensus 60c 10/21/20 Notable companies reporting before tomorrow's open 10/21/20 Notable companies reporting before tomorrow's open FITB Fifth Third $31.32 / -0.75 (-2.34%) 01/20/21 Notable companies reporting before tomorrow's open 01/20/21 Notable companies reporting before tomorrow's open 11/21/20 Citizens Financial, Truist among regional bank stocks to grab, Barron's says 08/15/20 PNC, KeyCorp among large regional banks offering steady dividends, Barron's says FITB Fifth Third $31.32 / -0.75 (-2.34%) 09/25/20 Cruise Line upgrades among today's top calls on Wall Street 09:00 Today Fifth Third - FITB
Hot Stocks	Climb Channel Solutions launches Climb Elevate » 07:11 01/21/21 01/21 07:11 01/21/21 07:11 WSTG Wayside Technology $19.57 / +0.11 (+0.57%) Climb Channel Solutions… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News WSTG Wayside Technology $19.57 / +0.11 (+0.57%) 01/19/21 Climb Channel Solutions partners with ChannelOnline 01/12/21 TechXtend, Resiliency Technologies announce national partnership 12/14/20 Climb Channel Solutions appoints Charles Bass as CMO 12/03/20 Climb Channel Solutions to distribute SUSE's open source solutions
Recommendations	Cinedigm price target raised to $3 from $2 at Alliance Global Partners » 07:10 01/21/21 01/21 07:10 01/21/21 07:10 CIDM Cinedigm $1.21 / +0.12 (+11.01%) Alliance Global Partners… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research CIDM Cinedigm $1.21 / +0.12 (+11.01%) 01/19/21 Cinedigm acquires Fandor, terms not disclosed 12/08/20 Cinedigm, Spherex partner on global content localization, compliance 11/30/20 Cinedigm acquires over 1,000 hours of premium film, TV programming 11/19/20 Cinedigm launching Whistle TV streaming channel on Roku Channel CIDM Cinedigm $1.21 / +0.12 (+11.01%) 10/16/20 Alliance Global Partners Cinedigm initiated with a Buy at Alliance Global Partners 07/07/20 Benchmark Cinedigm initiated with a Speculative Buy at Benchmark 07/07/20 Benchmark Cinedigm initiated with a Speculative Buy at Benchmark
Recommendations	Booking Holdings price target raised to $2480 from $2120 at Truist » 07:10 01/21/21 01/21 07:10 01/21/21 07:10 BKNG Booking Holdings $2,160.05 / -6.04 (-0.28%) Truist analyst Naved Khan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options BKNG Booking Holdings $2,160.05 / -6.04 (-0.28%) 11/16/20 Lone Pine buys Square, exits Visa in Q3 10/14/20 Eightfold.ai to modernize Booking.com's global talent acquisition processes 09/10/20 Booking Holdings to reduce Booking.com's global workforce by about 10% 08/17/20 Soros boosts stakes in Alphabet, T-Mobile, takes position in Alibaba BKNG Booking Holdings $2,160.05 / -6.04 (-0.28%) 01/08/21 Mizuho Booking Holdings price target raised to $2,345 from $2,020 at Mizuho 01/04/21 Fly Intel: Top five analyst initiations 01/04/21 Loop Capital Booking Holdings initiated with a Hold at Loop Capital 01/04/21 Deutsche Bank Booking Holdings price target raised to $2,585 from $1,985 at Deutsche Bank BKNG Booking Holdings $2,160.05 / -6.04 (-0.28%) 11/05/20 Booking CEO says COVID-19 surge to impact travel in near-term 11/05/20 Booking Holdings reports Q3 adjusted EPS $12.27, consensus $14.13 11/05/20 Notable companies reporting after market close 08/06/20 Booking Holdings reports Q2 adjusted EPS ($10.81), consensus ($11.70) BKNG Booking Holdings $2,160.05 / -6.04 (-0.28%) 09/29/20 Amazon gets into virtual tourism, with Amazon Explore, GeekWire reports BKNG Booking Holdings $2,160.05 / -6.04 (-0.28%) 01/04/21 Airbnb under pressure as Wall Street analysts roll out coverage following IPO 12/14/20 Disney, Airbnb downgrades among today's top calls on Wall Street 12/10/20 Tesla downgrade, Disney initiation among today's top calls on Wall Street 12/01/20 Pinterest, FedEx upgrades among today's top calls on Wall Street BKNG Booking Holdings $2,160.05 / -6.04 (-0.28%) 01/04/21 Booking Holdings put volume heavy and directionally bearish 09/03/20 Booking Holdings put volume heavy and directionally bearish

Events

Earnings calls, analyst events, roadshows and more

TFC
Today at 08:00

Truist Financial - TFC Conference Calls
SI
Today at 08:00

Silvergate Capital - SI Conference Calls
BEDU
Today at 08:00

Bright Scholar - BEDU Conference Calls
DFS
Today at 08:00

Discover - DFS Conference Calls
WNS
Today at 08:00

WNS Holdings - WNS Conference Calls
TAL
Today at 08:00

TAL Education - TAL Conference Calls
STL
Today at 08:00

Sterling Bancorp - STL Conference Calls
CTXS
Today at 08:15

Citrix - CTXS Conference Calls
PLXS
Today at 08:30

Plexus - PLXS Conference Calls
UNP
Today at 08:45

Union Pacific - UNP Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley Priced at: $25.50 700K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright Priced at: $17.50 5.484M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald Priced at: $1.90 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel Priced at: $22.00 15.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE Priced at: $11.50 4.99M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush Priced at: $13.00 9.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen Priced at: $26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities Priced at: $22.50 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright Priced at: $91.00 1.923M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading Priced at: $8.50 11.765M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler Priced at: $7.00 14.286M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel Priced at: $28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse Priced at: $66.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS Priced at: $66.00 3.788M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INO X INO Inovio Spot Secondary Managers: BofA, Jefferies & Cantor Fitzgerald, Oppenheimer Priced at: $8.50 2.655M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.30 7.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance $8.00-10.00 116.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink $24.71 Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ONCS X ONCS OncoSec Spot Secondary Managers: BTIG $5.76 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies $42.25 17.5M Shares CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen, & Stifel, Wedbush, Academy Securities $37.73 7.5M Shares DCBO X DCBO Docebo Secondary Managers: Morgan Stanley, Goldman Sachs & Canaccord $70.51 3.65M Shares NVTA X NVTA Invitae Secondary Managers: JPMorgan, Morgan Stanley, Cowen & SVB Leerink $56.93 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan $29.05 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SI X SI Silvergate Capital Secondary Managers: Goldman Sachs, Keefe Bruyette & Canaccord, Compass Point, Craig-Hallum $66.43 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Herbalife Nutrition participates in a conference call with Jefferies

TODAY'S FREE FLY STORIES

Get Full Fly Access